| Molecular evolution and secondary structural conservation in the B-cell lymphoma leukemia 2 (bcl-2) family of proto-oncogene products. | lymphoma,leukemia, |
| Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. | gastric, |
| Expression of BCL-2 proto-oncogene in adult acute lymphoblastic leukemia. | leukemia, |
| Quantitation of bcl-2 oncogene in cultured lymphoma/leukemia cell lines and in primary leukemia B-cells by a highly sensitive RT-PCR method. | lymphoma,leukemia, |
| Expression of bcl-2 oncoprotein in various types of glomerulonephritis and renal allografts. | kidney, |
| Expression of bcl-2 oncogene product in primary non-Hodgkin s malignant lymphoma of the oral cavity. | lymphoma, |
| [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. | lung, |
| [Bcl-2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue]. | thyroid, |
| Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. | leukemia, |
| Expression of the bcl-2 oncoprotein in meningiomas. | meningiomas, |
| Bcl-2 oncoprotein expression is increased especially in the portion of small cell carcinoma within the combined type of small cell lung cancer. | lung, |
| Expression of bcl-2 oncoprotein in pituitary tumours: comparison with c-myc. | pituitary, |
| Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer. | prostate, |
| bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis. | lung, |
| Expression of bcl-2 oncoprotein in gastrointestinal and uterine carcinomas and their premalignant lesions. | uterine, |
| Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival. | nasopharyngeal,laryngeal, |
| Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children s Cancer Group Study. | leukemia, |
| [Expression and significance of bcl-2 oncogene protein in follicular lymphoma and lymphoid follicular hyperplasia]. | lymphoma, |
| BCL-2 oncoprotein (p26) in splenic lymphoma with villous lymphocytes: a comparative study with other chronic B-cell disorders. | lymphoma, |
| Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias. | leukemia, |